New marine natural products, pulchranins B and C (2 and 3), were isolated from the marine sponge Monanchora pulchra and their structures were established using NMR and MS analysis. Compounds 2 and 3 were moderately active as inhibitors of TRPV1 (EC 50 value of 95 and 183 M, respectively) and less potent against TRPV3 and TRPA1 receptors.
Guanidine alkaloids represent a well-known group of marine secondary metabolites [1] [2] [3] . These compounds show a broad range of biological activities [1] [2] [3] [4] . As a result of our preliminary study on natural products from the Far-Eastern marine sponge Monanchora pulchra, we recently have published a short report concerning the isolation and structure of an unusual, low molecular weight secondary metabolite named pulchranin A (1), the first marine nonpeptide inhibitor of TRPV1 channels [8] .
In continuation of our search for new bioactive natural products from marine sponges [5] [6] [7] [8] , herein we report the isolation and structures of two new pulchranins, B and C (2, 3), from another collection of the sponge M. pulchra, as well as the inhibitory activities on TRPV1, TRPV3, and TRPA1 channels of pulchranin A (1) and the new alkaloids pulchranins B and C (2, 3).
The EtOH extract of M. pulchra was concentrated and partitioned between H 2 O and n-BuOH. After evaporation of the solvent, the BuOH-soluble materials were partitioned between n-hexane and aqueous EtOH. The ethanol-soluble materials were further subjected to repeated column chromatography on Sephadex LH-20 to obtain a mixture of guanidine alkaloids. Separation of the mixture and purification were carried out by repeated HPLC to provide pure pulchranin A (1) (9.1 mg, 0.20%), pulchranin B (2, 1.7 mg, 0.04%) and pulchranin C (3, 1.7 mg, 0.04%), respectively, based on the dry weight of the sponge.
Pulchranin B (2) gave an [M+H] + ionic peak at m/z 242.2227 in its HR ESI-MS, establishing its molecular formula as C 13 , for which the absolute configuration has been established [8] , thus suggesting the same (7R) configuration in 2. The molecular formula C 12 H 26 N 3 O of pulchranin C (3) , was obtained from the [M+H] + ion peak at m/z 228.2066 in the HR ESI-MS. The 1 H and 13 C NMR data (Table 1) of 3 almost coincided with those of pulchranin B (2), but the MS data showed the molecular mass for 3 is 14 amu less than that of 2, suggesting that the hydrocarbon chain in 3 was shortened by one CH 2 group in NPC Natural Product Communications 2013 Vol. 8 No. 9 1229 -1232 Structurally, pulchranins B and C consist of hydroxylated monounsaturated long hydrocarbon chains with 12 and 11 carbons, respectively, and a guanidine group. Pulchranin C has a structural fragment similar to that of (7S)-methoxydodec-4(E)-enoic acid (4), earlier isolated from a marine cyanobacterium belonging to the genus Lyngbya [9, 10] . This acid (4), as well as homologic lyngbic acid, form a hydrocarbon chain in the highly cytotoxic chlorinated amide derivatives malyngamides, which were first isolated in 1978 from the cyanobacterium Lyngbya majuscula [11, 12] . In contrast with these C-14 and C-12 acids, pulchranin A and C have a guanidine group instead of a carboxy group and do not contain a methoxyl group. The corresponding hydrocarbon structural fragment of pulchranin B has not been previously found in malyngamides.
Pulchranins A, B and C (1-3) showed some inhibitory activities against TRPV1, TRPV3 and TRPA1 receptors in the Fluo-4 based intracellular calcium assay [13] .
The action of pulchranins B and C, as well as pulchranin A, led to a concentration-dependent decrease of [Ca 2+ ] in CHO cells, expressed rTRPV1, hTRPV3 and rTRPA1. The inhibitory effect of pulchranins A, B and C on all TRP-expressing cells became apparent only after preincubation at 37°C for 30 minutes. (Table 2) .
Structure-activity relationship in a series of isolated puchranins shows that a C 14 -compound (1) is much more active than a C 13 -(2) and the latter is more active when compared with the C 12 -open chain bderivative 3 ( Table 2 ). On the basis of these results, we propose that the hydroxylated alkenyl moiety plays an important role in the inhibitory activity of pulchranins on TRPV1, as well as on TRPV3 and TRPA1 channels. Such observations agree well with previous reports for inhibitors of TRPV channels [14] . Actually, it was established that maximal activity in some series of compounds is dependent on an optimal hydrophobicity of their alkyl fragments for both the known inhibitors and agonists of these receptors.
TRPV1 and TRPV3 belong to the "vanilloid" subfamily of TRPreceptors and have about 40% identity of amino acid sequence. Both TRPV1 and TRPV3 are activated by 2APB. We checked if the mode of activation of TRPV1 is important for channel inhibition.
Pulchranin A inhibited the [Ca 2+ ] response in rTRPV1-CHO cells induced by capsaicin, as well as by 2APB with similar affinity (data not shown).
TRPA1 is a single member of the "ankirin" subfamily of TRPreceptors and phylogenetically it is the closest to TRPVs among all the TRP subfamilies. Like TRPV1, TRPA1 is activated by lidocaine, AITC, pungent extracts from garlic and onion and their active components, allicin and alliin. Carvacrol and thymol activate both TRPA1 and TRPV3. TRPV1, TRPV3 and TRPA1 belong to the group of thermosensitive ion channels with distinct thermal activation thresholds (>43°C for TRPV1, > 34−38°C for TRPV3, Guanidine alkaloids from the marine sponge Monanchora pulchra Natural Product Communications Vol. 8 (9) 2013 1231 and <17°C for TRPA1). The common features in channel pharmacology seem to be determined by common structural determinants responsible for specific interaction with agonists and antagonists. Apparently, pulchranins A, B and C have the common mechanism of action on TRPV1, TRPV3 and TRPA1 channels and interact with a similar structural motive on the channel surface.
In conclusion, two new guanidine natural products, pulchranins B and C (2, 3) have been isolated from the marine sponge M. pulchra. The structures were elucidated by spectroscopic analysis using 2D NMR techniques and HR ESI-MS analysis. All pulchranins interact with TRPV1, TRPV3 and TRPA1 channels. The most active of them is pulchranin A.
Experimental
General: Optical rotations were measured using a Perkin-Elmer 343 polarimeter. The 1 H and 13 C NMR spectra were recorded on Bruker DRX-500 and Avance III-700 spectrometers at 500, 700, and 125, and 175 MHz, respectively, with Me 4 Si as an internal standard. ESI mass spectra (including HR ESI-MS) were obtained on an Agilent 6510 Q-TOF LC-MS spectrometer by direct injection in MeOH. Low-pressure column liquid chromatography was performed using Sephadex LH-20 (Sigma Chemical. Co.). Si gel plates (4.5×6.0 cm, 5-17 µm, Sorbfil) were used for thin-layer chromatography and compounds were visualized by spraying with 10% H 2 SO 4 solution, followed by heating. HPLC was performed using an Agilent Series 1100 Instrument equipped with the differential refractometer RID-DE14901810 and a YMC-ODS-A (250×10 mm) column. 
Inhibitory activities on TRPV1, TRPV3 and TRPA1:
The CHO cell lines stably expressing rat TRPV1, human TRPV3 and rat TRPA1 were generated using T-Rex System (Invitrogene) according to the manufacturer's instructions and fluorescent assays were performed using NOVO star (BMG LABTECH, Germany) as described [8] . The buffer alone (control) or serial dilutions of pulchranins A, B and C were added to the cells loaded with the cytoplasmic calcium indicator Fluo-4AM. After a 30 min incubation at 37°C, changes in cell fluorescence ( ex =485 nM,  em =520 nM) were monitored before and after the addition of the relevant agonist (500 nM capsaicin, 200 M 2APB, 100 M AITC for rTRPV1, hTRPV3 and rTRPA1 correspondently). The measurements were performed at pH 7.4 and 25°C. Curve fitting and parameter estimations were performed with Microsoft Excel 2003 and Origin 7.0 (OriginLab Corporation, USA). The EC 50 values were determined as the concentration of test substance required to produce half-maximal decreases in [Ca 2+ ].
